Status:

COMPLETED

Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region

Lead Sponsor:

Hikma Pharmaceuticals LLC

Conditions:

Relapsing Remitting Multiple Sclerosis

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this observational study is to evaluate the effectiveness, safety and health related quality of life of Generic DMF (Sclera® or Marovarex ®, Hikma) in patients undergoing routine clinic...

Detailed Description

This is an observational, multi-center, prospective, cohort study, where no visits or intervention(s) additional to the daily practice will be performed. In the study sites, patients undergoing routin...

Eligibility Criteria

Inclusion

  • Patients who initiate treatment with Hikma Generic DMF at baseline in accordance with the approved Summary of Product Characteristics
  • Age ≥ 18 years
  • Patients who had a diagnosis of RRMS per 2010 or 2017 revised McDonald criteria who are :
  • Newly diagnosed who had no prior DMT, or
  • Switched patients who had ≥1 prior DMTs, other than DMF
  • Patients who agree to participate in the study and provide a written informed consent

Exclusion

  • Patients with previous exposure to DMF other than (Sclera® or Marovarex ®-Hikma), Fumaderm (fumaric acid esters), or compounded fumarates.
  • Patients participating in other clinical studies
  • Patients who meet any of the contraindications to the administration of the Study drug according to the approved Summary of Product Characteristics

Key Trial Info

Start Date :

February 23 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 20 2023

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT04468165

Start Date

February 23 2021

End Date

July 20 2023

Last Update

September 22 2023

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

CHU Frantz FANON

Blida, Algeria

2

Nedir Mohamed Hospital

Tizi Ouzou, Algeria

3

New University Hospital

Alexandria, Egypt

4

Demerdash hospital (Ain Shams University)

Cairo, Egypt